Although GLP-1 receptor agonists (GLP-1RAs) were initially developed for the management of diabetes and weight loss, their therapeutic applications have since broadened considerably to encompass a range of cardiovascular, renal, and metabolic disorders [15,16,17]
The FDA has asked Novo Nordisk and Eli Lilly to remove warnings about suicidal behavior and ideation from their GLP-1 products, an adjustment the agency says will help harmonize the messaging across the drugs in this class
This leads us to two big considerations that are critical to pair with GLP-1 weight loss: Incorporate resistance or strength workouts at least two or three times a week
Here are more things to keep in mind: Nootropics are compounds, whether natural or manmade dietary supplements, that are used to boost cognitive performance
This means it works by increasing the levels of norepinephrine and dopamine in the brain